UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| 1 |
Microsoft
MSFT
|
+$849M |
| 2 |
Apple
AAPL
|
+$707M |
| 3 |
Tesla
TSLA
|
+$370M |
| 4 |
iShares MSCI ACWI ETF
ACWI
|
+$354M |
| 5 |
Johnson & Johnson
JNJ
|
+$344M |
Top Sells
| 1 |
Salesforce
CRM
|
+$338M |
| 2 |
Meta Platforms (Facebook)
META
|
+$243M |
| 3 |
CTXS
Citrix Systems Inc
CTXS
|
+$223M |
| 4 |
iShares US Real Estate ETF
IYR
|
+$217M |
| 5 |
Vertiv
VRT
|
+$147M |
Sector Composition
| 1 | Technology | 13.92% |
| 2 | Healthcare | 9.62% |
| 3 | Financials | 9.19% |
| 4 | Consumer Discretionary | 6.32% |
| 5 | Industrials | 6.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2276
DaVita
DVA
$9.27B
| $2.8M | ﹤0.01% |
37,535
-2,614
| -7% | -$195K |
|
|
CDMO
2277
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $2.8M | ﹤0.01% |
203,537
+178,974
| +729% | +$2.46M |
|
2278
Nuveen New York Municipal Value Fund
NNY
$158M
| $2.8M | ﹤0.01% |
338,895
+42,460
| +14% | +$351K |
|
|
CNR
2279
Core Natural Resources, Inc.
CNR
$4.02B
| $2.8M | ﹤0.01% |
43,039
+38,822
| +921% | +$2.52M |
|
2280
Day One Biopharmaceuticals
DAWN
$728M
| $2.79M | ﹤0.01% |
129,857
+108,251
| +501% | +$2.33M |
|
2281
Insight Enterprises
NSIT
$3.79B
| $2.79M | ﹤0.01% |
27,863
+8,535
| +44% | +$856K |
|
2282
Recursion Pharmaceuticals
RXRX
$2.09B
| $2.79M | ﹤0.01% |
361,895
+343,430
| +1,860% | +$2.65M |
|
2283
Cracker Barrel
CBRL
$1.13B
| $2.79M | ﹤0.01% |
29,412
+12,888
| +78% | +$1.22M |
|
2284
WisdomTree Global High Dividend Fund
DEW
$124M
| $2.79M | ﹤0.01% |
59,515
-753
| -1% | -$35.2K |
|
2285
Gabelli Equity Trust
GAB
$1.88B
| $2.78M | ﹤0.01% |
508,035
+126,534
| +33% | +$693K |
|
2286
Prospect Capital
PSEC
$1.29B
| $2.78M | ﹤0.01% |
397,994
-12,954
| -3% | -$90.5K |
|
2287
Qualys
QLYS
$4.78B
| $2.78M | ﹤0.01% |
24,786
+15,683
| +172% | +$1.76M |
|
|
DCPH
2288
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $2.78M | ﹤0.01% |
169,340
+128,397
| +314% | +$2.1M |
|
2289
ALPS Medical Breakthroughs ETF
SBIO
$86.9M
| $2.76M | ﹤0.01% |
90,986
-86,457
| -49% | -$2.63M |
|
2290
Fidelity MSCI Consumer Staples Index ETF
FSTA
$1.35B
| $2.76M | ﹤0.01% |
61,649
-3,320
| -5% | -$149K |
|
2291
Petrobras Class A
PBR.A
$77B
| $2.76M | ﹤0.01% |
296,886
+33,036
| +13% | +$307K |
|
|
JKS
2292
JinkoSolar
JKS
$1.3B
| $2.76M | ﹤0.01% |
67,467
+13,429
| +25% | +$549K |
|
2293
Performance Food Group
PFGC
$16.7B
| $2.76M | ﹤0.01% |
47,233
+26,357
| +126% | +$1.54M |
|
|
PZC
2294
DELISTED
PIMCO California Municipal Income Fund III
PZC
| $2.76M | ﹤0.01% |
329,944
+54,215
| +20% | +$453K |
|
2295
First Citizens BancShares
FCNCA
$24.4B
| $2.74M | ﹤0.01% |
3,618
-4,900
| -58% | -$3.72M |
|
2296
BridgeBio Pharma
BBIO
$9.89B
| $2.74M | ﹤0.01% |
359,878
+351,065
| +3,983% | +$2.68M |
|
2297
ABM Industries
ABM
$2.77B
| $2.74M | ﹤0.01% |
61,655
+20,997
| +52% | +$933K |
|
2298
Teradata
TDC
$2.07B
| $2.74M | ﹤0.01% |
81,331
+63,540
| +357% | +$2.14M |
|
2299
Chemours
CC
$2.59B
| $2.73M | ﹤0.01% |
89,301
-51,752
| -37% | -$1.58M |
|
2300
Immunovant
IMVT
$2.7B
| $2.73M | ﹤0.01% |
153,875
+146,897
| +2,105% | +$2.61M |
|